Literature DB >> 19755617

Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis.

Gina Rohekar1, Janet Pope.   

Abstract

OBJECTIVE: As a guide to treatment of rheumatoid arthritis (RA), physicians use measurement tools to quantify disease activity. The Patient Global Assessment (PGA) asks a patient to rate on a scale how they feel overall. The Physician Global Assessment (MDGA) is a similar item completed by the assessing physician. Both these measures are frequently incorporated into other indices. We studied reliability characteristics for global assessments and compared test-retest reliability of both the PGA and the MDGA, as well as other commonly used measures in RA.
METHODS: We studied 122 patients with RA age 17 years or older. Patients who received steroid injection or change in steroid dose at the visit were excluded. Patients completed the HAQ, PGA, visual analog scale for pain (VAS Pain), VAS Fatigue, and VAS Sleep. After seeing their physician, they received another questionnaire to complete within 2 days at the same time of day as clinic visit. Physicians completed the MDGA at the time of the patient's appointment and at the end of their clinic day. Test-retest results were assessed using intraclass correlations (ICC). "Substantial" reliability is between 0.61-0.80 and "almost perfect" > 0.80.
RESULTS: Four rheumatologists and 146 patients participated, with 122 questionnaires returned (response rate 83.6%). Test-retest reliability was 0.702 for PGA, 0.961 for MDGA, and 0.897 for HAQ; VAS results were 0.742 for Pain, 0.741 for Fatigue, and 0.800 for Sleep. The correlation between PGA and MDGA was -0.172.
CONCLUSION: PGA, MDGA, HAQ, and VAS Pain, VAS Fatigue, and VAS Sleep all showed good to excellent test-retest reliability in RA. MDGA was more reliable than PGA. The correlation between PGA and MDGA was poor.

Entities:  

Mesh:

Year:  2009        PMID: 19755617     DOI: 10.3899/jrheum.090084

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  20 in total

1.  Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

Authors:  Nasim Ahmed Khan; Horace Jack Spencer; Essam Ahmed Abda; Rieke Alten; Christof Pohl; Codrina Ancuta; Massimiliano Cazzato; Pál Géher; Laure Gossec; Dan Henrohn; Merete Lund Hetland; Nevsun Inanc; Johannes Wg Jacobs; Eduardo Kerzberg; Maria Majdan; Omondi Oyoo; Ruben A Peredo-Wende; Zahraa Ibrahim Selim; Fotini Nikolaos Skopouli; Alberto Sulli; Kim Hørslev-Petersen; Peter C Taylor; Tuulikki Sokka
Journal:  Ann Rheum Dis       Date:  2012-04-24       Impact factor: 19.103

2.  Hand grip endurance moderating the effect of grip force on functional ability and disease activity in rheumatoid arthritis patients: a cross-sectional study.

Authors:  Ines Doko; Žarko Bajić; Amir Dubravić; Merita Qorolli; Simeon Grazio
Journal:  Rheumatol Int       Date:  2019-02-12       Impact factor: 2.631

3.  Discordance between physician and patient self-rated health and all-cause mortality.

Authors:  Karen B Desalvo; Paul Muntner
Journal:  Ochsner J       Date:  2011

4.  Relationship of negative affect and outcome of an opioid therapy trial among low back pain patients.

Authors:  Robert N Jamison; Robert R Edwards; Xiaoxia Liu; Edgar L Ross; Edward Michna; Meredith Warnick; Ajay D Wasan
Journal:  Pain Pract       Date:  2012-06-11       Impact factor: 3.183

5.  "From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ).

Authors:  Susan J Bartlett; Vivian P Bykerk; Orit Schieir; Marie-France Valois; Janet E Pope; Gilles Boire; Carol Hitchon; Glen Hazlewood; Louis Bessette; Edward Keystone; Carter Thorne; Diane Tin; Clifton O Bingham
Journal:  Qual Life Res       Date:  2022-09-08       Impact factor: 3.440

6.  Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors:  Pamela F Weiss; Timothy Beukelman; Laura E Schanberg; Yukiko Kimura; Robert A Colbert
Journal:  J Rheumatol       Date:  2012-10-15       Impact factor: 4.666

7.  Stability of clinical outcome measures in rheumatoid arthritis patients with stable disease defined on the basis of the EULAR response criteria.

Authors:  Ole Rintek Madsen
Journal:  Clin Rheumatol       Date:  2016-06-09       Impact factor: 2.980

8.  Definition of nonresponse to analgesic treatment of arthritic pain: an analytical literature review of the smallest detectable difference, the minimal detectable change, and the minimal clinically important difference on the pain visual analog scale.

Authors:  Melissa E Stauffer; Stephanie D Taylor; Douglas J Watson; Paul M Peloso; Alan Morrison
Journal:  Int J Inflam       Date:  2011-05-05

Review 9.  Measurement properties of physical function scales validated for use in patients with rheumatoid arthritis: a systematic review of the literature.

Authors:  Martijn A H Oude Voshaar; Peter M ten Klooster; Erik Taal; Mart A F J van de Laar
Journal:  Health Qual Life Outcomes       Date:  2011-11-07       Impact factor: 3.186

10.  Accessibility to biologics and its impact on disease activity and quality of life in patients with rheumatoid arthritis in Kuwait.

Authors:  Adeeba Al-Herz; Khuloud Saleh; Adel Al-Awadhi; Waleed Al-Kandari; Eman Hasan; Aqeel Ghanem; Mohammed Hussain; Yaser Ali; Ebrahim Nahar; Ahmad Alenizi; Sawsan Hayat; Fatemah Abutiban; Ali Aldei; Hebah Alhajeri; Naser Alhadhood; Husain Bahbahani; Hoda Tarakmeh; Khaled Mokaddem; Ahmad Khadrawy; Ammad Fazal; Agaz Zaman; Ghada Mazloum; Youssef Bartella; Sally Hamed; Ramia Alsouk; Ahmed Al-Saber
Journal:  Clin Rheumatol       Date:  2020-10-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.